Eliot Forster
CIK 1831558 · PRESIDENT AND CEO · last filed 2025-09-04
Eliot Forster is a PRESIDENT AND CEO who has filed 9 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for PLX, was dated Sep 4, 2025. Current disclosed insider exposure totals $15.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$15.7K
2
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLX | Director | 7,500 | $2.09 | $15.7K | $0 | 2 | 2025-09-04 |
| F-star Therapeutics, Inc. (FSTX) Delisted | PRESIDENT AND CEO | 73,959 | $7.12 | $526.6K | $0 | 7 | 2023-03-09 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-04 | PLX | Grant (A) | +7,500 | $0 | EDGAR |
| 2023-09-15 | PLX | Grant (A) | — | $0 | EDGAR |
| 2023-03-09 | F-star Therapeutics, Inc. (FSTX) Delisted | Mixed | −421,537 | -$3.00M | EDGAR |
| 2022-08-02 | F-star Therapeutics, Inc. (FSTX) Delisted | Exer (M) | +260,977 | $28.7K | EDGAR |
| 2022-04-04 | F-star Therapeutics, Inc. (FSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-11 | F-star Therapeutics, Inc. (FSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-11 | F-star Therapeutics, Inc. (FSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-02 | F-star Therapeutics, Inc. (FSTX) Delisted | Grant (A) | +142,000 | $0 | EDGAR |
| 2020-11-24 | F-star Therapeutics, Inc. (FSTX) Delisted | Grant (A) | +18,560 | $0 | EDGAR |